Neuromyelitis optica and astrocytic damage in its pathogenesis (Q33844069)

29 July 2017

1 reference

title

Neuromyelitis optica and astrocytic damage in its pathogenesis (English)

1 reference

29 July 2017

1 reference

Kazuo Fujihara

1 reference

29 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21396661

27 November 2024

publication date

11 March 2011

1 reference

full work available at URL

29 July 2017

https://api.elsevier.com/content/article/PII:S0022510X11000736?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

https://api.elsevier.com/content/article/PII:S0022510X11000736?httpAccept=text/plain

27 November 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Journal of the Neurological Sciences

27 November 2024

published in

1 reference

29 July 2017

volume

306

1 reference

29 July 2017

issue

1-2

1 reference

29 July 2017

page(s)

183-187

1 reference

Devic's neuromyelitis optica: a clinicopathological study of 8 patients

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

The clinical course of neuromyelitis optica (Devic's syndrome).

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

The spectrum of neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

OSMS is NMO, but not MS: proven clinically and pathologically

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Multiple sclerosis in the Japanese population

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Neuromyelitis optica and non organ-specific autoimmunity

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Neuromyelitis optica(Devic disease) and optic-spinal form multiple sclerosis

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

A secondary progressive clinical course is uncommon in neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Optical coherence tomography in neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Preferential spinal central gray matter involvement in neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Brain abnormalities in neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Occurrence of acute large and edematous callosal lesions in neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Revised diagnostic criteria for neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Plasma exchange for severe attacks of CNS demyelination: predictors of response

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Interferon-beta(1b) treatment in neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Intermittent plasmapheresis prevents recurrence in neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Neuromyelitis optica: Passive transfer to rats by human immunoglobulin

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

Neuromyelitis optica without typical opticospinal phenotype

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.02.018

27 November 2024

Identifiers

DOI

1 reference

29 July 2017

1 reference